Hansa Biopharma

    OverviewSuggest Edit

    Hansa Biopharma (previously known as Hansa Medical) is a biopharmaceutical company developing immunomodulating therapies. It offers an enzyme technology platform that helps to develop immunomodulatory treatments for rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer.


    Latest Updates

    Employees (est.) (Dec 2019)74

    Hansa Biopharma Online and Social Media Presence

    Embed Graph

    Hansa Biopharma News and Updates

    Hansa Biopharma Publishes Annual Report 2019

    LUND, Sweden, April 2, 2020 /PRNewswire/ -- Søren Tulstrup, President and CEO of Hansa Biopharma, comments: "2019 was an important and overall successful year for Hansa Biopharma - a year with significant progress across our pipeline and platform development activities and a year in which...

    Hansa Biopharma Frequently Asked Questions

    • When was Hansa Biopharma founded?

      Hansa Biopharma was founded in 2007.

    • How many employees does Hansa Biopharma have?

      Hansa Biopharma has 74 employees.

    • Who are Hansa Biopharma competitors?

      Competitors of Hansa Biopharma include ReNetX Bio, Entrada Therapeutics and Navega Therapeutics.